Source Report 1

Anthropic IPO Offer Price and Final Terms: 2026 Details

Full research prompt

Research the Anthropic IPO's final offer price versus the $70 to $78 marketed range, including whether it was priced above, within, or below range and any upsizing. Pull from the SEC S-1 and 424B4 prospectus, Reuters, Bloomberg, and WSJ coverage. Report shares sold (primary vs. secondary), the greenshoe, gross proceeds, listing exchange, ticker, and lead underwriters, in a table with sources. If no IPO has priced, state that clearly and describe the latest verified status.

From Anthropic IPO Valuation, Share Price and First-Day Trading Explained

Jon Sinclair using Luminix AI
Jon Sinclair using Luminix AI Strategic Research

The IPO has priced. On November 18, 2026, Anthropic, PBC set the Class A offer price at $83.00, above the marketed range of $70.00–$78.00, and upsized the deal. It is not still in the marketed range, and it is not unpriced.

The mechanism was a late, demand-driven reset of both price and size. The November 10, 2026 S-1/A (kept in the November 17 S-1/A) marketed 825 million Class A shares at $70–$78, with a 15% greenshoe of 123,750,000 shares. After the book was covered several times, the company raised the price $5 above the top of the range and added 155 million primary shares, taking the base deal to 980 million. Secondary size did not change. The greenshoe was reset to 15% of the new base, 147 million shares. Registration of the extra shares was done on Form S-1MEF on November 18; the final terms are in the Rule 424(b)(4) prospectus filed November 19. The SEC declared the S-1 effective November 18. Shares began trading November 19 on Nasdaq as ANT. Delivery was expected on or about November 20, 2026.

At $83, the base offering’s gross proceeds are $81,340,000,000 ($81.34 billion), the figure printed on the 424B4 cover. That is the IPO gross only. Headlines that say about $107.3 billion are adding a separate $26.0 billion concurrent private placement of non-voting Class N stock at the same $83 price. That placement is not part of the registered IPO and is not included in the $81.34 billion.

Deal terms

Item Final terms Marketed terms (S-1/A, Nov. 10 and Nov. 17, 2026) Sources
Offer price $83.00, above range ($5, or about 6.4%, above the $78 top; about 12% above the $74 midpoint) $70.00–$78.00 424B4 cover; company pricing release; Reuters; Bloomberg; WSJ
Above / in / below range Above — Same
Shares sold, total 980,000,000 Class A 825,000,000 Class A 424B4; company release
Primary (company) 956,351,354 801,351,354 424B4; company release
Secondary (selling stockholders) 23,648,646 (seven co-founders; company receives none of these proceeds) 23,648,646 (unchanged) 424B4; Bloomberg
Upsize +155,000,000 primary shares (+18.8% vs. 825 million; Reuters described it as about 19%) — 424B4 vs. S-1/A; Reuters; WSJ (“sold more shares than planned”); Bloomberg
Greenshoe (overallotment) 30-day option for up to 147,000,000 additional Class A shares from the company at the $83 IPO price. No underwriting discount on option shares. Full exercise would add $12.201 billion of gross proceeds (147 million × $83). Not known to have been exercised as of the Nov. 19 prospectus and Nov. 18 pricing release. Up to 123,750,000 shares (15% of 825 million) 424B4 cover footnote; company release
Gross proceeds (base IPO) $81,340,000,000 (980 million × $83). Cover table: proceeds before expenses to Anthropic $78,840,438,875; to selling stockholders $1,949,565,525; underwriting discount $550,000,000 ($0.56122 per share). $57.75–$64.35 billion at the range on 825 million shares 424B4 pricing table; Reuters ($81.3 billion); WSJ ($81 billion)
Exchange Nasdaq Global Select Market Nasdaq Global Select Market 424B4; company release
Ticker ANT ANT 424B4; company release
Lead underwriters Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC as representatives. Goldman was lead left; Morgan Stanley was second and the stabilization agent. Syndicate of 22 banks. Same lead pair named in the S-1 424B4 cover; Bloomberg (Oct. 26 roles); Reuters syndicate count; company release (prospectus copies from those two banks)

Primary gross at $83 is $79,377,162,382 (956,351,354 × $83). Secondary gross is $1,962,837,618 (23,648,646 × $83). Those two sum to the prospectus total of $81,340,000,000. The “proceeds before expenses” lines are after the $550 million discount, which is why they do not equal the gross.

What “above range and upsized” actually means

Pricing above the top of a filed range, rather than merely at the top, is the stronger signal. The company did not just clear a soft book at $78. It moved the clearing price outside the range investors had been shown on the roadshow, and it did so while also selling 155 million more primary shares. WSJ reported on November 17 that advisers were already discussing a price above $80 and a fully diluted value around $1.5–$1.6 trillion, versus roughly $1.33 trillion at the midpoint of the filed range. The print at $83 landed in that zone.

Reuters, Bloomberg, and WSJ all describe the same outcome: $83, above $70–$78, and a larger share count than planned. Bloomberg’s count of the upsize matches the filings: the company had marketed 801.4 million shares and the co-founders 23.6 million; the final sale was 956.4 million by the company and 23.6 million by the co-founders. Secondary was not upsized. The extra capital is new primary issuance.

The greenshoe is structurally unusual in one respect that is on the face of the 424B4: underwriters receive no discount or commission on the option shares. They can still buy up to 147 million shares at $83 for 30 days, which is the stabilization tool, but the fee pool of $550 million is only on the base 980 million shares. That is the same concession reported on SpaceX’s June 2026 IPO.

What is not in the $81.34 billion

Immediately after the IPO, and contingent on it, seven strategic buyers agreed to purchase $26.0 billion of non-voting Class N stock at $83: Google and NVIDIA about $10.0 billion each, AMD about $2.5 billion, Broadcom, Micron, and Microsoft about $1.0 billion each, and TSMC about $500 million (313,253,007 Class N shares in total). Underwriters take no fee on those shares. Bloomberg and Reuters add that placement to the IPO and report a combined $107.3 billion. The 424B4 estimates net proceeds to Anthropic from its IPO shares plus the placement at about $104.8 billion, or about $117.0 billion if the greenshoe is exercised in full. Those figures are not IPO gross proceeds.

Latest verified status (as of November 20, 2026)

The offering has priced and has begun trading. It is not a pending deal.

  • November 18, 2026: priced at $83; registration statement effective; 30-day greenshoe granted.
  • November 19, 2026: 424B4 filed; first trade on Nasdaq Global Select Market under ANT. Shares opened at $111.50 (about 34% above $83) and closed at $97.17 (about 17% above the offer price), per Reuters and WSJ live coverage.
  • On or about November 20, 2026: expected closing and delivery, subject to customary conditions, as stated in the company release and the 424B4. Whether the greenshoe has been exercised is not in the pricing release or the November 19 prospectus.

Fully diluted value at the $83 offer price was reported at about $1.5 trillion by Reuters, Bloomberg, and WSJ. That is a valuation at the offer price, not the first-day trading value.


Recent Findings Supplement (November 2026)

Anthropic priced its IPO above the marketed range on November 18, 2026, at $83 per Class A share (vs. the $70–$78 range set in the November 10 S-1/A amendment). The offering was upsized by ~19% to 980 million shares amid strong demand (book reportedly ~6x oversubscribed), making it the largest IPO on record by proceeds raised.[1][2]

Trading began on the Nasdaq Global Select Market under ticker ANT on November 19, 2026. The company also raised $26 billion via a concurrent private placement of non-voting Class N shares to seven strategic partners (Google, Microsoft, Nvidia, AMD, Broadcom, Micron, TSMC) at the same $83 price, for a combined total of $107.3 billion.[3][4]

Key offering details (from final pricing, 424B4 prospectus, and contemporaneous coverage):

  • Final price vs. range: $83/share, above the $70–$78 marketed range (and above the ~$74 midpoint).[2]
  • Upsizing: Base offering increased from 825 million shares to 980 million shares (+155 million primary shares via S-1MEF).[5]
  • Shares sold:
    • Primary (Anthropic): 956,351,354 Class A shares.
    • Secondary (selling stockholders/co-founders): 23,648,646 Class A shares.[6]
  • Gross proceeds (IPO only): ~$81.3 billion (980 million shares × $83).[2]
  • Greenshoe/underwriters’ option: Up to 147 million additional Class A shares from the company (30-day option).[7]
  • Listing/exchange/ticker: Nasdaq Global Select Market; ANT.[2]
  • Lead underwriters/representatives: Goldman Sachs & Co. LLC (lead left) and Morgan Stanley & Co. LLC (stabilization agent); broader syndicate of ~22–23 banks.[8][9]

The 424B4 final prospectus (filed ~November 19, 2026) and related S-1 amendments/S-1MEF filings on EDGAR (CIK 0002130357) contain the definitive terms, consistent with Bloomberg, Reuters, and other coverage from November 18–19, 2026.[10]

No material changes or new regulatory updates to these terms have been reported since pricing. Shares opened at $111.50 (34% pop) on November 19 before closing at ~$97.17 (up ~17%).[11]

Sources for table/facts above: Primarily Bloomberg (Nov 18–19, 2026), Reuters (Nov 18–19, 2026), company pricing release/424B4 details via SEC filings and aggregators (Nov 19, 2026), and contemporaneous WSJ/FT/Forbes reporting. All post-date May 20, 2026, and reflect the most recent verified information as of November 20, 2026.

Get Custom Research Like This

Start Your Research